DR. SHARIAR COHEN-GADOL M.D. NPI 1013054865

NPI Details

DR. Shariar Cohen-gadol, M.D. is a rheumatology internal medicine in Thousand Oaks, CA with 24 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Shariar Cohen-gadol, M.D. NPI is 1013054865. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

566 SAINT CHARLES DR
THOUSAND OAKS, CA
ZIP 91360-953
Phone: (805) 449-8781
Fax: (805) 449-4224

The NPI 1013054865 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D2313704 - physician office with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, infliximab-axxq, biosimilar, (avsola), 10 mg (HCPCS:Q5121)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection of drug or substance into vein (HCPCS:96374)
• Complete ultrasound scan of joint (HCPCS:76881)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Methotrexate sodium, 5 mg (HCPCS:J9250)
• X-ray of knee, 3 views (HCPCS:73562)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• X-ray of wrist, minimum of 3 views (HCPCS:73110)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of pelvis, minimum of 3 views (HCPCS:72190)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• X-ray of knee, 4 or more views (HCPCS:73564)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• X-ray of chest, 2 views (HCPCS:71046)
• X-ray of ankle, minimum of 3 views (HCPCS:73610)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Injection into tendon or ligament (HCPCS:20550)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Injection of anesthetic agent and/or steroid into lower back and leg nerve (HCPCS:64445)
• X-ray of both hips, 3-4 views (HCPCS:73522)
• Dxa bone density measurement of forearm, finger, hand, or foot (HCPCS:77081)

The enumeration date for this NPI number is 1/31/2007 and was last updated on 8/12/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.